Latest filing published 21 Jan 2026 for Immuneering Corp, €22k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -30.1%Entry US$5.34 · Close 23 Oct 2026 US$3.73
- +50.0%Entry US$3.02 · Close at T+365 US$4.53
- -31.4%Entry US$2.39 · Close at T+365 US$1.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Harold Eugene Brakewood: trading record in brief
All filings by Harold Eugene Brakewood on record concern Immuneering Corp. We count 3 filings; the first trade dates from 22 March 2024 and the latest from 16 January 2026.
The open-market record is one-sided, with 3 purchases worth €35k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €9,220. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of +10.3%, with the price up in 67% of them. They describe history only and say nothing certain about the share price ahead.
The newest entry dates from 21 January 2026: an open-market purchase of €22k, in Immuneering Corp. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harold Eugene Brakewood
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,250 shares@ US$4.7661.6% of flowClass A Common StockSEC:0001790340-26-000016:0Canonical exit: 16 Apr 2026 (T+90)
- 1,900 shares@ US$2.528512.0% of flowClass A Common StockSEC:0001790340-25-000085:0Canonical exit: 18 Sept 2025 (T+90)
- 3,900 shares@ US$2.56826.4% of flowClass A Common StockSEC:0001790340-24-000040:0Canonical exit: 20 Jun 2024 (T+90)
3 of 3 declarations
